Colloidal Bismuth Subcitrate is a bismuth-containing antimicrobial agent and prokinetic drug primarily used to treat peptic ulcer disease and facilitate Helicobacter pylori eradication by inhibiting bacterial… Read more
Colloidal Bismuth Subcitrate is a bismuth-containing antimicrobial agent and prokinetic drug primarily used to treat peptic ulcer disease and facilitate Helicobacter pylori eradication by inhibiting bacterial urease activity and reinforcing gastric mucosal defenses. Laboratories utilize this collection of reference standards, including the active pharmaceutical ingredient, identified impurities, metabolites, and stable isotope-labelled compounds, to perform rigorous analytical testing and quality control. These materials are essential for conducting precise impurity profiling and validating analytical methods, such as HPLC or mass spectrometry, ensuring accurate characterization of the drug substance. By incorporating these high-quality standards into development and testing workflows, researchers can effectively monitor degradation products and confirm consistency in pharmaceutical preparations, ultimately supporting compliance with pharmacopeial requirements and safety standards throughout the drug development lifecycle.